Sun Pharmaceuticals
Meitar’s litigation group successfully represented the India-based Sun Pharmaceuticals (NSE: SUNPHARMA; BSE: 524715) in its legal proceedings against Israel-based Taro Pharmaceutical Industries (PINK: TAROF). The Supreme Court accepted Sun’s argument that under Israel’s Companies Law Sun is exempt from commencing a special tender offer in order to gain control over Taro.